lipid-lowering therapy


Also found in: Acronyms.

lipid-lowering therapy

drugs, dietary and lifestyle regimes directed toward restoring blood lipids to normal levels
Mentioned in ?
References in periodicals archive ?
Nonetheless, 40% of patients received no lipid-lowering therapy in the 3 months before the ASCVD event and 90% received no high-intensity statins.
Docs letting high-risk diabetes slip through the lipid net
A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia.
Some keys to dyslipidemia care in people with HIV: an interview with Christopher Longenecker, MD
All T2DM patients of either gender with fasting lipid profile irrespective of receiving lipid-lowering therapy were included.
Importance of measuring Non-HDL cholesterol in type 2 diabetes patients
In any case, it makes sense to maintain a low-cholesterol diet and to consider lipid-lowering therapy, including statins or niacin.
Is it true that moderate alcohol
Approximately one-third of the patients experienced levels of LDL-C that were less than 100 mg/dl - close to the recommended therapeutic goals- at some point during the study, and concomitant lipid-lowering therapy was modified in a subset of these patients during the safety phase.
New drug holds promise as therapy for rare and deadly cholesterol disorder
Table 1 summarizes data for age, sex, body mass index, current smoking, and use of lipid-lowering therapy for these individuals (with and without diabetes) according to the time since the last meal.
Using nonfasting lipids--hemodilution or convenience?
Thirteen of the 23 patients were able to have their background lipid-lowering therapy reduced during the Safety Phase of the study (between Week 26 and Week 56).
Aegerion unveiled 56-week data for its compound Lomitapide
After adjusting for age, hypertension, smoking, alcohol consumption, atrial fibrillation, lipid-lowering therapy, and--in women--hormone replacement therapy and menopausal status, the researchers found that women with triglycerides above 445 milligrams per deciliter (mg/dL) had a four-fold increased risk for stroke compared with women whose non-fasting triglycerides were below 90 mg/dL.
Lower your triglyceride levels and cut your stroke risk: triglycerides don't get the attention that LDL and HDL get in determining your total lipid profile, but these fats pose real threats to your health
Furthermore, placebo recipients who cross over to lipid-lowering therapy in the open-label phases of the studies demonstrate survival benefits as well, but never attain the protection achieved by being randomized to active treatment earlier on, according to Dr.
Benefits of lipid-lowering agents persist after trials end
4) Combination lipid-lowering therapy is therefore not routinely indicated and should only be initiated at specialist level.
Best of ... more about: cardiovascular protection in type 2 diabetes mellitus
This double-blind, placebo-controlled Phase III study was designed to test the efficacy and safety of adding mipomersen to stable lipid-lowering therapy.
Genzyme, Isis present Phase III study data for mipomersen in heFH patients
All of three studies demonstrated significant clinical benefit by intensive lipid-lowering therapy.
Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels

Medical browser ?
Full browser ?